Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
77°
Site search
Search
Menu
Subscribe
Home
News
Local News
Sports
Obituaries
Photos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Explore the Sheyenne
Best of 2023
Archives
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Ayala Pharmaceuticals Inc
(NQ:
AYLA
)
N/A
UNCHANGED
Last Price
Updated: 3:56 PM EST, Jan 18, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
0
Open
-
Bid (Size)
0.5000 (200)
Ask (Size)
0.5597 (25)
Prev. Close
0.5036
Today's Range
N/A - N/A
52wk Range
N/A - N/A
Shares Outstanding
1
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
12 Health Care Stocks Moving In Tuesday's After-Market Session
January 10, 2023
Via
Benzinga
Stocks That Hit 52-Week Lows On Tuesday
January 03, 2023
On Tuesday, 31 stocks hit new 52-week lows.
Via
Benzinga
Performance
More News
Read More
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
December 27, 2022
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
November 29, 2022
Via
Benzinga
Recap: Ayala Pharmaceuticals Q3 Earnings
November 04, 2022
Via
Benzinga
Stocks That Hit 52-Week Lows On Wednesday
October 19, 2022
Via
Benzinga
Ayala Pharmaceuticals Presents Poster on AL102 in Desmoid Tumors at the Connective Tissue Oncology Society (CTOS) 2022 Annual Meeting
November 17, 2022
From
Ayala Pharmaceuticals
Via
GlobeNewswire
Ayala Pharmaceuticals Announces First Patient Dosed with AL102 in Phase 3 Segment of RINGSIDE Trial in Desmoid Tumors
November 16, 2022
From
Ayala Pharmaceuticals
Via
GlobeNewswire
Ayala Pharmaceuticals Reports Third Quarter 2022 Financial Results and Provides Corporate Update
November 04, 2022
From
Ayala Pharmaceuticals
Via
GlobeNewswire
Stocks That Hit 52-Week Lows On Friday
November 11, 2022
Via
Benzinga
AutoZone To Rise Over 9%? Plus Roth Capital Slashes PT On This Stock By 96%
October 20, 2022
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
October 19, 2022
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 31, 2022
October 31, 2022
Via
Benzinga
Ayala Pharmaceuticals and Advaxis Agree To Combine, Expect Uplisting On NASDAQ
October 19, 2022
Via
Benzinga
AYLA Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Ayala Pharmaceuticals, Inc. Is Fair to Shareholders
October 19, 2022
From
Halper Sadeh LLC
Via
Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For October 20, 2022
October 20, 2022
Via
Benzinga
Ayala Pharmaceuticals and Advaxis Enter into Merger Agreement
October 19, 2022
From
Ayala Pharmaceuticals
Via
GlobeNewswire
12 Health Care Stocks Moving In Monday's Pre-Market Session
October 17, 2022
Via
Benzinga
Why Olaplex Shares Dipped Around 57%; Here Are 75 Biggest Movers From Yesterday
October 20, 2022
Via
Benzinga
Why United Airlines Shares Are Trading Higher? Here Are 43 Stocks Moving In Wednesday's Mid-Day Session
October 19, 2022
Via
Benzinga
Short Volatility Alert: Ayala Pharmaceuticals, Inc.
October 03, 2022
Via
Benzinga
Ayala Pharmaceuticals to Host Key Opinion Leader Webinar on Desmoid Tumors
September 29, 2022
From
Ayala Pharmaceuticals
Via
GlobeNewswire
Why NLS Pharmaceutics Shares Dipped Over 23%; Here Are 67 Biggest Movers From Yesterday
September 28, 2022
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
September 20, 2022
Via
Benzinga
Analyzing Ayala Pharmaceuticals's Short Interest
September 13, 2022
Via
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.